The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.
Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.
12. March 2024 to 14. March 2024 — Register Here
DIA Europe 2024 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2024 will be the prime opportunity to discuss how collaboration… read more
12. March 2024 to 13. March 2024 — Register here
The world-leading healthcare evidence, pricing, and access congress is taking place in Amsterdam in 2024. The main topics that will be covered during the event are the following: Market Access, Rare Diseases, Evidence, Pricing, Emerging Markets, HTA/Payers, Advanced Therapies, Health Economics & Outcomes Research, Patient… read more
19. March 2024 to 20. March 2024 — Register Here
The Future of Advanced Therapies 19th-20th March – ExCel, London The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators. New for 2024: Gene Editing… read more
16. April 2024 — Register here
Against the backdrop of the Belgian EU Council Presidency, the forum will bring together senior leaders from across patient organisations, industry and policy to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda and strengthen the case for EU… read more
15. May 2024 to 16. May 2024 — Registration Details
Action Within Reach: Pioneering Solutions for Rare Diseases. The European Conference on Rare Diseases & Orphan Products (ECRD) is the largest, patient-led policy-shaping conference for rare diseases taking place in Europe. ECRD is an instrumental tool to achieve policy objectives for people living with a… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Enrico Piccinini, Head of Europe & International Rare Diseases, Chiesi Global Rare Diseases Enrico… read more
We are looking for a dedicated and experienced ‘Project Manager’ to support a multi-stakeholder genomics coalition at the EU level In this role you will provide the Secretariat function for a newly established multi-stakeholder coalition at the EU level, the European Coalition for Access to… read more
We are looking to recruit a dynamic and experienced Communications & Business Development Manager to shape and implement our communication strategies, grow the organisation and develop new partnership opportunities Location: On-site Job type: Full time Responsibilities: Developing and coordinating external and internal communications strategies; Drafting… read more
On 14 December, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the fourth episode of its #LifeScienceLectures webinar series. The focus of the webinar, titled “Leveraging early advice opportunities in EU HTA” was to discuss how best to navigate early advice opportunities with the new… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In November, we spoke with Kenneth Saké – Vice President of International Medical Affairs, Blueprint Medicines. Tell us about… read more
4 December 2023, Brussels – EUCOPE, as part of a large multi-stakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 36 European patient organisations, medical associations, health research infrastructures and health industry associations, have issued a joint statement to alarm bells… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of 9 new members at its quarterly Members Meeting on October 18th, 2023 following Board approval. The new members joining the EUCOPE network are Angelini Pharma, Dipharma, Italfarmaco, Labcorp, Metriopharm AG, Otsuka, Pharming Group, Pharvaris… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Margarida Duarte, Senior Vice President, Head of International, Deciphera Pharmaceuticals. Margarida Duarte is Senior… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Heike Kielhorn, Managing Partner from SKC. Heike Kielhorn-Schönermark studied business administration and economics in… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Francois Lontrade, Directeur General, Laboratoire Cevidra. Before joining Cevidra, Francois Lontrade gained 18 years’… read more
... or browse news by Tag
EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.